EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From the gene to the clinic: Key milestones in the PI3Kδ journey

Bart Vanhaesebroeck

The Journal of Immunology · 14.05.2026 · 215 (5)

DOI: 10.1093/jimmun/vkag075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 19.05.2026. Verfasst von Bart Vanhaesebroeck. Beteiligte Einrichtung: UCL Cancer Institute, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Neoplasms, Class I Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ludwig Institute for Cancer Research, Cancer Research UK, UK Research and Innovation (Biotechnology and Biological Sciences Research Council, Medical Research Council), European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among the PI3K isoforms, PI3Kδ has attracted particular attention from immunologists and hematologists. Despite earlier clinical setbacks, the PI3Kδ field has recently re-emerged with renewed promise. Here, I highlight key milestones in the evolving understanding of PI3Kδ signaling in immunity and cancer, and pivotal studies that have shaped this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesNeoplasmsClass I Phosphatidylinositol 3-KinasesHumansSignal TransductionAnimals

Stichwörter der Autor:innen

PI3K, PI 3-kinase, signaling, cancer, leukemia, lymphoma, drug, medicine

Substanzen

Phosphatidylinositol 3-KinasesClass I Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • UCL Cancer Institute, University College London, London, United Kingdom.

Förderung

  • Ludwig Institute for Cancer Research, Cancer Research UK
  • UK Research and Innovation (Biotechnology and Biological Sciences Research Council, Medical Research Council)
  • European Union
  • Cancer Research UK
  • European Union's Horizon 2020 Research and Innovation Programme under Marie Skłodowska-Curie
  • Sarah Conduit and Klaus Okkenhaug
  • Klaus Okkenhaug and Sara Al-Jarrah Seto
  • European Union’s Horizon 2020 Research and Innovation Programme under Marie Skłodowska-Curie

Zitieren

APA

Vanhaesebroeck, B. (2026). From the gene to the clinic: Key milestones in the PI3Kδ journey. The Journal of Immunology, 215(5). https://doi.org/10.1093/jimmun/vkag075

Vancouver

Vanhaesebroeck B. From the gene to the clinic: Key milestones in the PI3Kδ journey. The Journal of Immunology. 2026;215(5). doi:10.1093/jimmun/vkag075

BibTeX
@article{Vanhaesebroeck2026,
  author = {Vanhaesebroeck, Bart},
  title = {From the gene to the clinic: Key milestones in the PI3Kδ journey},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {5},
  doi = {10.1093/jimmun/vkag075}
}
Kostenlos starten →